Triple Bio Raises $1.7M Seed Round to Develop Lipid-Based Feed Additive Platform for Dairy Cows

Why It Matters

The dual focus on emissions and milk output gives farmers a clear economic incentive, accelerating adoption of climate‑friendly dairy practices and supporting carbon‑credit markets.

Key Takeaways

• Triple Bio raised $1.7M to develop lipid feed additives.
• RumeNRG-PL can cut methane inhibitor dose 500‑fold.
• In‑vitro tests showed 28% VFA rise, suggesting 5‑10% milk boost.
• Live‑cow trials slated for later 2026 before next funding round.

Pulse Analysis

Dairy cattle are responsible for a sizable share of global methane emissions, prompting regulators in the EU, US and emerging carbon‑credit schemes to demand measurable reductions. Traditional approaches have focused on outright methanogen suppression, which can disrupt rumen balance and raise safety concerns. Triple Bio’s strategy—leveraging lipid chemistry to both protect existing inhibitors and re‑engineer hydrogen flow—offers a more nuanced solution that aligns with sustainability mandates while preserving animal health.

The core of RumeNRG lies in mimicking methanogen cell‑membrane properties. By encapsulating bromoform‑type inhibitors, RumeNRG‑PL shields the active compound from rumen degradation, enabling a 500‑fold dose cut and lowering both cost and toxicity risk. Meanwhile, the standalone RumeNRG‑Mx1 formulation captures free hydrogen, making it more bioavailable to fermentative bacteria, which in turn boosts volatile fatty‑acid production—a key driver of milk synthesis. Early laboratory simulations recorded a 28% VFA increase, a figure that, if replicated in vivo, could translate into a 5‑10% rise in milk yield, delivering a compelling return on investment for dairy operators.

Commercially, the technology benefits from using readily available industrial lipids, sidestepping the need for novel manufacturing processes and reducing scale‑up risk. With live‑animal trials scheduled for late 2026, Triple Bio aims to validate feed‑conversion gains and methane‑reduction claims before a planned Series A round next year. Successful validation could position the company as a bridge between climate‑tech investors and pragmatic farmers, unlocking new revenue streams from both productivity premiums and carbon‑credit markets.

Deal Summary

Netherlands‑based startup Triple Bio emerged from stealth and raised just over €1.5 million ($1.7 million) from investors Nucleus Capital, Positron Ventures and Climate Club. The funding will support development of its lipid‑based feed additive platform RumeNRG, which aims to boost milk yields and cut methane emissions from cattle. The round marks the company’s first external capital after being founded by Marble’s climate‑tech studio.